A Mother’s Heartbreak: The Silent Crisis of Lafora Disease
A Michigan mother, Azeza Kasham, is facing an unimaginable tragedy as two of her sons battle Lafora disease, a rare and fatal genetic condition. This devastating illness, impacting roughly one in 10 million people, is thrusting a spotlight on the challenges faced by families navigating ultra-rare diseases and the urgent need for continued research.
Understanding Lafora Disease: A Rapidly Progressing Condition
Lafora disease is a progressive neurological disorder typically beginning in adolescence. Symptoms initially manifest as seizures, followed by a decline in neurodevelopmental abilities, cognitive impairment, and difficulties with motor skills like walking and talking. Dr. Nancy McNamara, division chief of Pediatric Neurology at Corewell Health, describes it as “one of the worst diseases that you could have.” Currently, there is no cure, only medication to manage symptoms.
The disease stems from a faulty gene carried unknowingly by both parents. Hiatham Breadiy was diagnosed at 16 in 2017 and tragically passed away in 2019. Just ten days after his death, his younger brother, Gigi, received the same heartbreaking diagnosis.
The Weight of Loss and a Race Against Time
Azeza Kasham is now focused on providing comfort and care for Gigi, who is currently in the late stages of the disease. “I often think about this one being one of the worst diseases that you could have,” she shared with Fox 2 Detroit. She describes the agonizing experience of watching the disease rob her son of his abilities and the looming reality of losing him.
The family’s hope was recently diminished as research into a potential cure was halted due to a pharmaceutical sale. This setback underscores the fragility of progress in rare disease research and the impact of external factors on families seeking treatment options.
Raising Awareness and Seeking Support
Kasham is actively raising awareness about Lafora disease, hoping to connect with other families and advocate for increased research funding. She shares Gigi’s journey on Instagram, documenting the challenges and triumphs of living with this devastating illness. She emphasizes the emotional and financial strain the disease places on families, highlighting the need for support systems and resources.
“As his mother, I want to protect him, comfort him, and enable him to live as safely and with as much dignity as possible – but so much of that is beyond my control,” Kasham stated.
The Challenges of Ultra-Rare Diseases
Lafora disease exemplifies the broader challenges faced by individuals and families affected by ultra-rare diseases. These conditions often lack widespread recognition, leading to delayed diagnoses, limited treatment options, and a lack of research funding. The small patient population makes it difficult to conduct clinical trials and develop effective therapies.
The story of the Kasham family serves as a poignant reminder of the importance of continued investment in rare disease research and the need for compassionate support for those affected.
Frequently Asked Questions About Lafora Disease
- What causes Lafora disease? We see caused by a genetic mutation inherited from both parents.
- What are the first symptoms of Lafora disease? Typically, the first symptoms are seizures during adolescence.
- Is there a cure for Lafora disease? Currently, there is no cure, only treatments to manage symptoms.
- How rare is Lafora disease? It affects approximately one in 10 million people.
Did you know? Rare Disease Day is observed annually on the last day of February to raise awareness and advocate for those living with rare diseases.
Pro Tip: If you or someone you know is experiencing symptoms of a rare disease, seek a diagnosis from a qualified medical professional and connect with patient advocacy groups for support and information.
Learn more about Lafora disease and support research efforts at People.com and Fox 2 Detroit.
Share your thoughts and experiences in the comments below. Let’s work together to raise awareness and support families affected by rare diseases.
Worth a look